⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15796098 | 0.82 | OPRM1 (0.32) | — | |
| SCHEMBL15795366 | 0.78 | SMN1; SMN2 (0.32) | — | |
| SCHEMBL15795898 | 0.78 | — | — | |
| SCHEMBL15795970 | 0.77 | — | — | |
| SCHEMBL15795096 | 0.76 | P2RX7 (0.31) | — | |
| SCHEMBL17501715 | 0.72 | — | — | |
| SCHEMBL4702292 | 0.69 | CTSL (0.32) | — | |
| SCHEMBL14910753 | 0.69 | — | — | |
| SCHEMBL1645775 | 0.65 | CYP2D6 (0.39) | — | |
| SCHEMBL22733964 | 0.62 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070149525-A1 | Methods of treating amyloidosis using aryl-cyclopropyl derivative aspartyl protease inhibitors | ELAN PHARMACEUTICALS, INC. | 2007-06-28 | — | — | US | disclosed |